16 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
knowledge of the drug discovery industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
, a life science focused investment firm with a focus on investments in innovative and transformative early and growth stage healthcare and life
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic inflammatory diseases … biopharmaceutical company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic
6-K
EX-99.1
a2zz4ue2
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
EX-99.1
fic sxzukmmaokl6y
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
b7yyn
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
20-F
ke503 0qri5jhbzk
31 Mar 22
Annual report (foreign)
4:33pm
424B4
drzfz 8k50pnyvhk
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
4s1hb uuxn
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
iwrtkk56nkrlgd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
3zqem12ne
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
rcgdrvpqgq469rs3tex
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
l96156 jk06aocll5w
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next